1
APPENDIX
List of Published Guidelines, Policies and Recommendations Published Ascertained in the PubMed
Horizon Scan for the CDC Genomics and Health Impact Weekly Update, May 16, 2012- May 15, 2013.
PubMed ID
Topic
Organization
22855150
Guidelines for biomarker testing in colorectal cancer
SSP and SSMO
23360189
BRAF testing for melanoma treatment
UK Expert panel
23401870
Treating BRAF V600 positive melanoma
NICE
23408351
Clinical management of Lynch syndrome
European expert panel
22964825
Screening for ovarian cancer
USPSTF
23188549
Counseling for hereditary breast and ovarian cancer
NSGC
23551194
Testing in lung cancer for EGFR/ALK TK inhibitors
CAP, IASLC, AMP
23429431
EGFR testing in colorectal cancer
EGAPP
22685257
Molecular Genetics for gastrointestinal tumor
UK NEQAS
23619274
Microarray chromosomal analysis in cancer
ACMG
23012255
Management of colorectal cancer
ESMO
Cancer
Pharmacogenomics
2
22617227
SLCO1B1 testing in simvastatin-induced myopathy
CPIC
23422873
TPMT genotype and thiopurine dosing
CPIC
23486447
CYP2D6/CYP2C19 and dosing of antidepressants
CPIC
23232549
HLA-B genotype and allopurinol dosing
CPIC
23238534
Testing/treatment HLA antibodies in transplantation
Australian expert panel
23169492
Direct-to-consumer genetic testing
EASAC and FEAM
23348768
Oversight of laboratory-developed tests
ACMG
22918138
Clinical diagnostic genome sequencing
AMP
22892534
Genetic counseling for presymptomatic testing
UK expert group
22617616
Personalized genomic testing for disease risk
ACOG
22605523
Electronic family health history meaningful use
US federal regulation
22621421
Gene patents
US Supreme Court
General
Specific conditions
23519317
Clinical genetics evaluation of autism
ACMG
23288205
MTHFR polymorphism testing
ACMG
3
23492873
Genomic profiling to assess type 2 diabetes risk
EGAPP
22944025
Genetic testing for inherited eye diseases
AAO
21577118
Genetic counseling and testing for Alzheimer disease
ACMG, NSGC
Cardiovascular disease
22962670
Evaluation and treatment of hypertriglyceridemia
ESCGS
22645291
Genetics and cardiovascular disease
AHA
23578468
Management of familial hypercholesterolemia
NSFA
Prenatal Testing
23179172
Prenatal testing options for chromosome aneuploidy
NSGC
23558255
Noninvasive prenatal screening for fetal aneuploidy
ACMG
23619275
Prenatal/preconception expanded carrier screening
ACMG
20966460
PGD/preimplantation genetic screening
ESHRE
23334531
Noninvasive prenatal testing
NSGC
Newborn screening
22947299
Economic evaluation of newborn screening
Expert group
4
23037933
Newborn screening numbers on birth certificates
SACHDNC
ACMG: American College of Medical Genetics and Genomics; AAO: American Academy of
Ophthalmology; AHA: American Heart Associations; AMP: Association for American Pathologists; CAP:
College of American Pathologists; CPIC: Clinical Pharmacogenomics Implementation Coalition; EASAC:
European Academies of Science Advisory Council; EGAPP: Evaluation of Genomic Applications in Practice
and Prevention; ESCGS: Endocrine Society Clinical Guidelines Subcommittee;
ESHRE: European Society for Human Reproduction and Embryology; FEAM: Federation of European
Academies of Medicine; NSGC: National Society for Genetic Counselors; NICE: National Institute for
Clinical Excellence; NSFA: New French Society of Atherosclerosis; SACHDNC: Secretary’s Advisory
Committee on Diseases of Newborns and Children; UKNEQAS: United Kingdom National External Quality
Assessment Service